HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Collaborative Management of Patients With Estrogen Receptor-Positive Breast Cancer.

Abstract
Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust.
AuthorsLee S Schwartzberg, Heather R Greene
JournalJournal of the advanced practitioner in oncology (J Adv Pract Oncol) Vol. 8 Issue 3 Pg. 250-254 (Apr 2017) ISSN: 2150-0878 [Print] United States
PMID29928547 (Publication Type: Journal Article, Review)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: